Fundstrat Granny Shots US Large Cap ETFGRNY

The Fundstrat Granny Shots US Large Cap ETF (GRNY) is the latest entrant in the crowded US large-cap ETF market, but its name promises more than its holdings deliver. Launched to market with the kind of homespun charm that makes “Granny Shots” sound like a stock-picking secret handed down from a matriarch who’s beaten the market since the Reagan era, the reality is a plain-vanilla basket of US large-cap stocks with a 0.45% expense ratio. The fund’s Nasdaq listing confirms it’s trading, but the issuer’s marketing materials don’t explain why the source directs readers to pay up for a strategy that could be replicated for a fraction of the cost elsewhere.

GRNY’s mandate is to provide exposure to US large-cap equities, but the fund’s holdings are as predictable as a boomer’s retirement portfolio: Apple, Microsoft, Nvidia, and the usual suspects that dominate any broad US equity index. The SEC’s EDGAR filing confirms the fund’s existence and regulatory status, but it doesn’t reveal anything about the holdings, performance, or why the Granny Shots angle is anything more than a marketing gimmick. The fund’s expense ratio, at 0.45%, is the only number that stands out in the filing-unless you count the lack of detail about the basket itself.

The FINRA Fund Analyzer lists GRNY’s total annual operating expenses at 0.45%, but it doesn’t provide AUM, liquidity metrics, or performance data. The fund’s Nasdaq page confirms it’s trading, but that’s the extent of the public evidence today. The fund’s tracking method is a rules-based index tracker, which is corporate speak for “we promise to hug the benchmark like a limpet on a yacht.” The issuer’s marketing suggests Granny Shots are the secret sauce, but the SEC filing reveals the sauce is store-bought Heinz ketchup-recognisable, safe, and unlikely to steal the show.

There’s The source-change rail is filing/source-led and does not use chart-derived signals. Chart context is available separately on this page through the Atlas chart snapshot or TradingView route where available. What we do know is that GRNY is trading, it’s subject to a 0.45% fee, and its holdings are the usual large-cap suspects. The fund’s liquidity and AUM aren’t public today, but the Nasdaq listing confirms it’s live. The real tension isn’t whether GRNY will relative strength, but whether investors will notice the difference between this and a cheap S&P 500 ETF by the time the fee’s eaten the first cup of coffee.

What remains unproven today is the fund’s actual holdings beyond the Nasdaq listing’s ticker page, its AUM, liquidity metrics, and performance track record. The evidence also doesn’t explain why the Granny Shots marketing angle is anything more than a way to justify a 0.45% fee. If the issuer were to publish a holdings breakdown, performance data, or a clear explanation of the Granny Shots methodology, the file would deepen substantially. Until then, the fund is trading, the fee is real, and the Granny Shots are likely in someone’s spreadsheet, not their stock portfolio.